Obtaining patent protection for fermentation processes and products – the European perspective

Tanis Keirstead

Tanis Keirstead
19 Sep 2019

Fermented foods have been known for millennia and form an important part of many national cuisines. Initially used primarily to preserve foods and.

Food of the future – regulating and protecting gene-edited crops

Simon Kremer

Simon Kremer
11 Sep 2019

A recent episode of the BBC World Service’s excellent series “50 Things that made the modern economy” (now up to ‘thing’ 75) concerned plant breeding.

DIY biology dilemma – regulating biohacking

Camille Terfve

Camille Terfve
04 Sep 2019

Science kits may have inspired generations of children to become scientists, and those grown up children might be surprised that there may be cause for.

Shifting treatments: cancer as a manageable disease

Nick Sutcliffe

Nick Sutcliffe
29 Aug 2019

As new treatments drive a shift towards treating cancer as a manageable disease we are seeing greater collaboration across the life sciences sector.  

Patentable subject matter in bioinformatics - USPTO’s January 2019 guidance

Camille Terfve

Camille Terfve
15 Aug 2019

In this article, Paul Liu and Ashley Barton from Duane Morris LLP provided some interesting thoughts about ways to obtain US patents in the field of.

Challenges Post­ Selex

Richard Clegg

Richard Clegg
13 Aug 2019

Twenty­-five years ago Tuerk and Gold reported the Selex method. Being the first European patent attorney to prosecute patents relating to.

The rise of predictive medicine

Frances Salisbury

Frances Salisbury
05 Aug 2019

Thanks to significant advances in genetics, we are not only getting better at diagnosing disease, but also at predicting disease. Predictive medicine.

Cultured meat - food for thought

Adam Gregory

Adam Gregory
23 Jul 2019

Cultured meat is rapidly emerging alongside plant-and microorganism-based alternative meat products as a future ‘clean meat’.  It is made by growing.

New Rules of Procedure at the Boards of Appeal – what does this mean for patentees and opponents?

Emily Hayes

Emily Hayes
09 Jul 2019

Revised Rules of Procedure at the Boards of Appeal have been approved by The Administrative Council of the EPO. The Rules will come into force on 1.

Gender medicine – deriving novelty from treating women?

Frances Salisbury

Frances Salisbury
26 Jun 2019

When you hear the term “gender medicine”, what comes to mind? For many people, the term is associated with reproductive health issues, such as.

Singapore biotech start-ups: the importance of patent protection

Adam Gregory

Adam Gregory
21 Jun 2019

Singapore’s biotech industry plays a key role in shaping the country’s future economy. This is largely thanks to an initiative launched in 2000 aimed.

Tips from the top: inspiring women in technology

Anna Mudge

Anna Mudge
19 Jun 2019

You may be surprised to hear that only 17% of those working in Technology in the UK are female. With this figure in mind, it’s important that others.

EU approves first gene therapy for patients with a mild form of β-Thalassemia

Frances Salisbury

Frances Salisbury
04 Jun 2019

Exciting news in the personalised medicine space – the EU has just approved the first gene therapy for patients with a mild form of β-Thalassemia. .

Precision therapeutics for the precision medicine era

Adam Gregory

Adam Gregory
17 May 2019

In recent years we have seen dramatic advances in our understanding of the intricate and dynamic relationships that underpin our immune responses. This.

Personalised medicine: patient stratification

Simon Kiddle

Simon Kiddle
29 Apr 2019

While the general idea of customising treatment to patients is not new, the degree to which treatments may be tailored to patient subgroups defined by.

Pioneers of precision medicine

Frances Salisbury

Frances Salisbury
15 Apr 2019

Breakthroughs in healthcare promise a future in which the individual sits at the centre of medical decisions. But who has paved the way and who is.

Dosage regimen patents: bruised but not beaten

Julie Carlisle

Julie Carlisle
28 Mar 2019

Ruling on the big pharma Actavis v ICOS case, the UK Supreme Court has found ICOS’s Cialis patent to be invalid for obviousness.

Playing for time: strategies that can help extend a drug's patent life

Emily Hayes

Emily Hayes
25 Mar 2019

In our new magazine Forward, we interview C Hunter Baker of Wolf, Greenfield & Sacks PC.  Hunter explores a typical drug development timeline and.

Can the EPO hold oral proceedings in Haar without infringing a party’s right to be heard?  A new referral to the Enlarged Board raises this question.

Sean Constable

Sean Constable
06 Mar 2019

The right to be heard under Article 113(1) EPC requires that parties involved in proceedings before the EPO have the right to present their arguments at.

Bioinformatics Inventions: Patenting challenges at the interface of computer and life sciences

Frances Salisbury

Frances Salisbury
27 Feb 2019

We are entering an age of precision medicine, with patients receiving tailored treatments, selected and sometimes even specifically designed for their.